The Kantorow Laboratory and research program have been continually funded by the NIH’s National Eye Institute for almost two decades.

Nicotinamide, a form of vitamin B3, can inhibit aggressive cell transformations during wound healing and may be key to the development of therapies to treat fibrotic eye diseases that impair vision.

A species of a lipid that naturally helps skin injuries heal appears to also aid repair of common corneal injuries, even when other conditions, like diabetes, make healing difficult, scientists report.

A protein that normally deposits mineralized calcium in tooth enamel may also be responsible for calcium deposits in the back of the eye in people with dry age-related macular degeneration (AMD).

In 2017, approximately 93 million US adults aged 18 years or older, or about 4 in 10, were at high risk for vision loss, according to a new study published in JAMA Ophthalmology.

Researchers turn back the biological hands of time, making adult cells revert to a primitive state with the potential to replace and repair retinal blood vessels.

Researchers at Case Western Reserve University have used a unique method to safely deliver gene therapy to fight a rare, but irreversible, genetic eye disorder known as Stargardt disease.

An artificial intelligence (AI) device that has been fast-tracked for approval by the Food and Drug Administration may help identify newborns at risk for aggressive posterior retinopathy of prematurity (AP-ROP). AP-ROP is the most severe form of ROP.

Computer model of face processing could reveal how the brain produces richly detailed visual representations so quickly.

According to a study from Emory University, as young as six days a baby’s brain appears hardwired for the specialized tasks of seeing faces and seeing places.